• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Medical Equipment/Devices
  • Sub-Industry: Health Care Supplies

Cytori Therapeutics Inc

+ Add to Watchlist


2.2200 USD 0.0100 0.45%

As of 20:10:00 ET on 07/11/2014.

Snapshot for Cytori Therapeutics Inc (CYTX)

Open: 2.2100 Day's Range: 2.1600 - 2.2400 Volume: 361,739
Previous Close: 2.2100 52wk Range: 2.0000 - 3.9300 1-Yr Rtn: -19.27%

Stock Chart for CYTX

No chart data available.
  • CYTX:US 2.2200
  • 1D
  • 1M
  • 1Y
Interactive CYTX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CYTX

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.4720
Est. EPS (USD) (12/2014) -0.4200
Est. PEG Ratio -
Market Cap (M USD) 176.51
Shares Outstanding (M) 79.51
30 Day Average Volume 383,456
Price/Book (mrq) 69.7410
Price/Sale (ttm) 22.7132
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/08/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CYTX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for CYTX

Cytori Therapeutics, Inc. discovers and develops cell-based therapeutics utilizing adult stem cells derived from fat tissue. The Company's investigational therapies target cardiovascular disease, spine and orthopedic conditions, gastrointestinal disorders, and new approaches for aesthetic and reconstructive surgery.

Marc H HedrickPresident/CEOMark E SaadChief Financial Officer
Steven KestenExec VP/Chief Medical OfficerClyde W ShoresExec VP:Marketing & Sales
More Company Profile & Key Executives for CYTX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil